AKT1 and type 2 diabetes mellitus: The present findings do not support this, but are corroborated by our earlier studies in which we showed that activin A derived from EAT from T2D patients impairs cardiomyocyte insulin sensitivity by inhibiting the insulin-mediated phosphorylation of Akt through induction of microRNA-143 [6,26].